Company intelligence / Profile preview

Thync Global, Inc.

Menlo Park, California, United Statesthync.com ↗

Ownership: Private
Employees: ~7
Development stage: Commercial

Overview

Thync’s non-invasive neurostimulation devices have demonstrated significant reductions in stress and anxiety as well as improvements in sleep quality. In a pilot study for plaque psoriasis, 83% of treated patients reported at least a 50% reduction in symptoms after four weeks with no reported side effects. The company is generating further clinical data through collaborations with academic institutions such as UCSF.

Therapeutic areas: PsychiatryDermatologyNeurology
Modalities: DeviceNon-pharmacological therapyBioelectronic therapy
Industry: Therapeutic Medical Devices

Drug pipeline

2 assets

FeelZing Energy Patch

Commercial

Indications: Energy enhancement, Mental clarity, Focus

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Thync Global, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thync Global, Inc..

Explore the full profile